December 06, 2007

66 yr old woman w/ increasing dyspnea x 1 month - Michael Bundesmann, MD

Clin Chest Med. 2006 Jun;27(2):309-19. The undiagnosed pleural effusion. Light RW.

Chest. 2005 Mar;127(3):1017-22. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Ferrer J, Roldán J, Teixidor J, Pallisa E, Gich I, Morell F.

J Thromb Haemost. 2006 Apr;4(4):724-31. Diagnosis and management of subsegmental pulmonary embolism. Le Gal G, Righini M, Parent F, van Strijen M, Couturaud F.

Lung Cancer. 2006 Oct;54(1):1-9. Epub 2006 Aug 7. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Neragi-Miandoab S.

Radiology. 2006 Jul;240(1):246-55. Epub 2006 May 9. Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Gladish GW, Choe DH, Marom EM, Sabloff BS, Broemeling LD, Munden RF.

AJR Am J Roentgenol. 2007 Jul;189(1):162-70. Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. Cronin CG, Lohan DG, Keane M, Roche C, Murphy JM.

N Engl J Med. 2003 Jul 10;349(2):146-53.
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators.

December 05, 2007

How low can you go - Sam Nadler, MD

Articles to be announced.

Posted by lsarmas at 10:58 AM | Comments (0)